Published in Sci Rep on August 05, 2016
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol (2008) 38.00
Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res (2011) 14.82
ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol (2014) 13.40
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res (2012) 13.14
Chagas disease. Lancet (2010) 10.25
Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. N Engl J Med (2014) 4.77
Control of Chagas disease. World Health Organ Tech Rep Ser (2002) 4.00
Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest (2008) 3.59
Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz (2007) 3.51
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature (2010) 2.90
Amino-terminal processing of proteins by N-myristoylation. Substrate specificity of N-myristoyl transferase. J Biol Chem (1987) 2.86
Purification and characterization of yeast myristoyl CoA:protein N-myristoyltransferase. Proc Natl Acad Sci U S A (1987) 2.36
β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc Natl Acad Sci U S A (2010) 2.28
N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence. J Mol Biol (2002) 2.18
Myristoyl CoA:protein N-myristoyltransferase activities from rat liver and yeast possess overlapping yet distinct peptide substrate specificities. J Biol Chem (1988) 2.17
Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites. J Biol Chem (2002) 2.08
Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach. Nat Chem (2013) 1.95
SMP-1, a member of a new family of small myristoylated proteins in kinetoplastid parasites, is targeted to the flagellum membrane in Leishmania. Mol Biol Cell (2004) 1.95
N-Terminal myristoylation predictions by ensembles of neural networks. Proteomics (2004) 1.67
Flagellar protein localization mediated by a calcium-myristoyl/palmitoyl switch mechanism. EMBO J (1999) 1.59
Comparative SILAC proteomic analysis of Trypanosoma brucei bloodstream and procyclic lifecycle stages. PLoS One (2012) 1.50
CAP5.5, a life-cycle-regulated, cytoskeleton-associated protein is a member of a novel family of calpain-related proteins in Trypanosoma brucei. Mol Biochem Parasitol (2001) 1.49
Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani. Chem Biol (2015) 1.47
Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother (2013) 1.45
MYRbase: analysis of genome-wide glycine myristoylation enlarges the functional spectrum of eukaryotic myristoylated proteins. Genome Biol (2004) 1.42
Chromosome level assembly of the hybrid Trypanosoma cruzi genome. BMC Genomics (2009) 1.42
Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs. PLoS Negl Trop Dis (2012) 1.36
Kinetic and structural evidence for a sequential ordered Bi Bi mechanism of catalysis by Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Biol Chem (1991) 1.34
Functional analysis of TbARL1, an N-myristoylated Golgi protein essential for viability in bloodstream trypanosomes. J Cell Sci (2005) 1.30
Unexpected protein families including cell defense components feature in the N-myristoylome of a higher eukaryote. J Biol Chem (2003) 1.28
Trypanosoma brucei ARF1 plays a central role in endocytosis and golgi-lysosome trafficking. Mol Biol Cell (2006) 1.26
A comparative study of methylglyoxal metabolism in trypanosomatids. FEBS J (2008) 1.26
New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice. J Infect Dis (2013) 1.23
Kinetoplastid PPEF phosphatases: dual acylated proteins expressed in the endomembrane system of Leishmania. Mol Biochem Parasitol (2006) 1.21
Cell death in parasitic protozoa: regulated or incidental? Nat Rev Microbiol (2012) 1.20
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects. Trends Parasitol (2014) 1.20
Global profiling of co- and post-translationally N-myristoylated proteomes in human cells. Nat Commun (2014) 1.19
Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J Exp Med (1988) 1.18
Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events. Proc Natl Acad Sci U S A (2006) 1.13
A novel phosphatidylinositol-phospholipase C of Trypanosoma cruzi that is lipid modified and activated during trypomastigote to amastigote differentiation. J Biol Chem (2000) 1.09
S-myristoylation of a glycosylphosphatidylinositol-specific phospholipase C in Trypanosoma brucei. J Biol Chem (1999) 1.02
Identification and biosynthesis of N1,N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione) in Trypanosoma cruzi. Eur J Biochem (1994) 0.96
Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy. Biopolymers (1997) 0.96
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors. J Med Chem (2014) 0.95
N-myristoylation of the Rpt2 subunit regulates intracellular localization of the yeast 26S proteasome. Biochemistry (2012) 0.94
Proteomic analysis of detergent-solubilized membrane proteins from insect-developmental forms of Trypanosoma cruzi. J Proteome Res (2009) 0.92
Mass-tag labeling reveals site-specific and endogenous levels of protein S-fatty acylation. Proc Natl Acad Sci U S A (2016) 0.87
Chagas disease (American trypanosomiasis) – fact sheet (revised in August 2012). Wkly Epidemiol Rec (2012) 0.87
Biochemical and genetic characterization of Trypanosoma cruzi N-myristoyltransferase. Biochem J (2014) 0.87
Regulation of co- and post-translational myristoylation of proteins during apoptosis: interplay of N-myristoyltransferases and caspases. FASEB J (2012) 0.85
High-throughput profiling of N-myristoylation substrate specificity across species including pathogens. Proteomics (2013) 0.84
Fatty acylation of proteins: The long and the short of it. Prog Lipid Res (2016) 0.81
N-Myristoylation is essential for protein phosphatases PPM1A and PPM1B to dephosphorylate their physiological substrates in cells. Biochem J (2013) 0.81
Extracellular amastigotes of Trypanosoma cruzi are potent inducers of phagocytosis in mammalian cells. Cell Microbiol (2013) 0.80
Determination of N-myristoyl peptide sequence both by MALDI TOF MASS and with an N-myristoyl cleaving enzyme (polymyxin acylase). Biochem Biophys Res Commun (1995) 0.79
Trypanosoma brucei AMP-activated kinase subunit homologs influence surface molecule expression. Exp Parasitol (2009) 0.79
Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma brucei. ACS Infect Dis (2016) 0.77
Demyristoylation of myristoylated alanine-rich C kinase substrate. Biochem Soc Trans (1995) 0.76
Lipid alterations induced by nifurtimox in Trypanosoma cruzi. Mol Biochem Parasitol (1986) 0.76